Bayer Aktiengesellschaft (BAYRY)
| Previous Close | 7.77 |
| Open | 7.81 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 7.76 - 7.84 |
| 52 Week Range | 6.96 - 14.90 |
| Volume | |
| Avg. Volume | 2,091,383 |
| Market Cap | 30.886B |
| Beta (5Y Monthly) | 0.97 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.03 (0.38%) |
| Ex-Dividend Date | Apr 29, 2024 |
| 1y Target Est | N/A |
- Newsfile
MustGrow Biologics and Bayer Sign Commercial License Agreement for Biocontrol Technologies in Europe, Middle East and Africa
Bayer's commercial license covers soil applications of MustGrow's mustard-based biocontrol technologies in Europe, Middle East and Africa. MustGrow to receive upfront license fees and milestone payments, royalties, and manufacturing sales linked to development and commercial achievements. Saskatoon, Saskatchewan--(Newsfile Corp. - December 11, 2023) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) ("MustGrow") is pleased to announce the signing of a collaboration agreement (the
- ACCESSWIRE
Designing the Keys To Unlock the Future of Sustainable Protection
Bayer - As climate change quickens, societal expectations increase and the threat of resistance grows, new crop protection solutions are imperative.
- ACCESSWIRE
Bayer is Using Unprecedented Insights in Unexpected Ways on the Farm
NORTHAMPTON, MA / ACCESSWIRE / August 10, 2023 / What's the value of data? Well, like any other tool, it depends on how you use it. In agriculture, data is proving to be an essential foundation for building more efficient, productive and profitable ...
